Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) Announces U.S. Launch of Generic Abilify; Remains in Patent Litigation with Otsuka

April 28, 2015 3:22 PM
Teva Pharma (NYSE: TEVA) announced the launch of the generic equivalent to Abilify (aripiprazole) Tablets, 2 mg, 5 mg, 10 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Litigation Management Comments

Next Articles